"Let's continue to work together as a team to advance our field." Inspiring words from our Editor-in-Chief @bfaquin. 🔬 . 🎥 Watch Dr. Faquin's full message below, then catch up with what's new in Cancer Cytopathology: #CytoPath

🔬Revisit this free article from 2023! | Diagnostic role of FNA cytology in the evaluation of cervical lymph nodes in thyroid cancers: Combined evaluation of thyroglobulin in eluate from FNA #cytology. #CytoPath @PathPro @DianaEstherossi @Elena_Navarra_

🔬 Our new Practice Essentials series offers concise, expert-authored guides to navigating diagnostic challenges in cytopathology—ideal for both trainees and seasoned pathologists!. Explore the series: @bfaquin @MichiyaNishino @MauroSaieg #CytoPath

New! | Diagnostic accuracy and risk stratification of pancreatic cyst fluids diagnosed as mucinous neoplasms without mucinous epithelium. #CytoPath @MLisaZhang @prisciladigonMD

🔔New! DICER1 mutations in Bethesda category II, III, and IV thyroid nodules: A mutually exclusive relationship with BRAFV600E mutation. #CytoPath

New and #OpenAccess | The combined analysis of SHOX2 and RASSF1A methylation demonstrated promising diagnostic accuracy for MPE detection, outperforming cytology. #CytoPath @theAJNR_EIC @MohamedSmailAi1 @ElhadiMuhammed

The HGDDS demonstrated excellent performance in detecting significant Pap test findings, w/ close to 100% sensitivity (98.2%–100%) for cases classified as ASC-US. More findings at: #CytoPath @lharinat @PathPro

This review covers all relevant aspects of #telecytology for ROSE, including digital pathology options, operators, validation, quality assurance, reimbursement, and recommendations from professional organizations. 🌹 . @MDAndersonNews #CytoPath

#OpenAccess! | The role of the ThyGeNEXT oncogene panel used in combination with the expanded miRNA panel ThyraMIRv2 in Indeterminate #thyroid nodules: A large, blinded, real-world, observational study. #CytoPath CC: @MichiyaNishino

🌍#OpenAccess | Nuclear membrane irregularity is an important, but not definitive, cytomorphologic criterion in HGUC diagnosis. @cjvand @JHUPath #CytoPath #morphology #bladder #ParisSystem

⚠️ The (2022) WHO Reporting System for #Pancreaticobiliary #Cytopathology: Overview and Summary. Includes new categories, features, pertinent ancillary studies, and more. @marthabpitman @MauroSaieg @mtsiddi @fcschmitt

💡 #OpenAccess from @UMichPath investigators | Malignant risk of pediatric Bethesda category III thyroid nodules subcategorized by nuclear atypia and other: A single institution experience. #CytoPath #BethesdaSystem #ENTpath

#OpenAccess! | Current role of #cytopathology in the molecular & computational era: The perspective of young #pathologists. New avenues for collaboration, education, and remote consultation are opening. #CytoPath @ACaputoMD @VLimperioMD @PasqualePisapia

New #CytoSource! Untangling the mystery of rising breast cancer rates. In part 1 of 2, researchers are grappling with spiking rates of specific breast cancers, particularly among younger women. @bfaquin

Just published and #OpenAccess! | Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System. #CytoPath @lharinat @PathPro

RT @IACytology: We look very much forward to Prof. @DianaEstherossi's #IACwebinar on 26th June at 13:00 CEST. Register now for this free we….

Cancer Cytopathology’s 2024 Impact Factor has risen to 3.2. We are grateful to our authors, editors, and reviewers for advancing high quality #CytoPath research and contributing to the journal’s continued growth!

#Telecytology for rapid on-site assessment is becoming a necessity in cytology practices. The landscape of telecytology is evolving with the availability of different options, each of which has advantages and limitations. @MDAndersonNews #CytoPath

There are certain differences in thyroid cytopathology practice between Western and Asian countries, which affect the major outputs of the #BethesdaSystem for Reporting Thyroid Cytopathology. Revisit this 2019 top-cited review: #CytoPath #ENTPath

📌 Revisit this March 2025 study from @Sinchita_Roy @Aiims1742 @Tony_Y_Hu et al! An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid. #CytoPath

#OpenAccess! Timely recognition of TFE3-rearranged renal cell carcinoma’s distinct cytomorphologic and histomorphologic features is essential for accurate diagnosis and effective treatment. @IUMedSchool @NU_Pathology #CytoPath